09062x10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 09062x10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 09062x10 Today - Breaking & Trending Today

Biogen (NASDAQ:BIIB) PT Raised to $342.00 at HSBC

Biogen (NASDAQ:BIIB – Get Free Report) had its price objective boosted by equities researchers at HSBC from $339.00 to $342.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. HSBC’s price target would indicate a potential upside of 57.23% […] ....

United States , Priya Singhal , Erick Rowinsky , Piper Sandler , Pinnacle Associates Ltd , Raymond James Associates , Cantor Fitzgerald , Securities Exchange Commission , Biogen Inc , Commonwealth Equity Services , Stratos Wealth Advisors , Stratos Wealth Partners , Get Free Report , Exchange Commission , Director Eric , Equity Services , Wealth Partners , Wealth Advisors , Biogen Daily , Nasdaq Biib , Boost Price Target , Hsbc Holdings Plc ,

6,088 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by Summit Global Investments

Summit Global Investments purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 6,088 shares of the biotechnology company’s stock, valued at approximately $1,575,000. Several other institutional investors have also recently made changes to […] ....

United States , Erick Rowinsky , Priya Singhal , Great Valley Advisor Group Inc , First Trust Direct Indexing , Biogen Inc , Hexagon Capital Partners , Needham Company , Wells Fargo Company , Securities Exchange Commission , Summit Global Investments , Free Report , Valley Advisor Group , Wealth Partners , Capital Partners , Director Eric , Wells Fargo , Get Free Report , Visit Holdingschannel , Biogen Daily , Nasdaq Biib , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Summit Global Investments Makes New $1.58 Million Investment in Biogen Inc. (NASDAQ:BIIB)

Summit Global Investments bought a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 6,088 shares of the biotechnology company’s stock, valued at approximately $1,575,000. Several other large investors also recently bought and sold shares of BIIB. International Assets […] ....

United States , Erick Rowinsky , Priya Singhal , International Assets Investment Management , Jpmorgan Chase Co , Biogen Inc , American Century Companies Inc , Massachusetts Financial Services Co , Associates Corp , Securities Exchange Commission , Summit Global Investments , Free Report , Assets Investment Management , Financial Services , American Century Companies , Century Companies , Director Eric , Exchange Commission , Truist Financial , Get Free Report , Visit Holdingschannel , Biogen Daily , Nasdaq Biib , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Biogen's (BIIB) Outperform Rating Reiterated at Oppenheimer

Oppenheimer reissued their outperform rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research report report published on Monday morning, Benzinga reports. The brokerage currently has a $270.00 target price on the biotechnology company’s stock. Several other research analysts have also recently weighed in on the stock. Truist Financial reiterated a buy rating […] ....

United States , Erick Rowinsky , Robertw Baird , Priya Singhal , Canaccord Genuity Group , Rise Advisors , Royal Bank , Biogen Inc , Wells Fargo Company , Biogen Company Profile , Securities Exchange Commission , Kb Financial Partners , Free Report , Genuity Group , Moderate Buy , Stock Down , Get Free Report , Exchange Commission , Director Eric , Asset Management , Financial Advisory , Capital Management , Biogen Daily , Nasdaq Biib , Reiterated Rating , Oppenheimer Holdings Inc ,

Biogen Inc. (NASDAQ:BIIB) Receives $295.58 Average PT from Analysts

Biogen Inc. (NASDAQ:BIIB – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twenty-seven brokerages that are currently covering the firm, MarketBeat reports. Nine research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. The average 1 year price objective […] ....

United States , Erick Rowinsky , Priya Singhal , Cantor Fitzgerald , Royal Bank , Sequoia Financial Advisors , Partners Investment Advisory , Financial Group , Biogen Inc , Ballentine Partners , Stratos Wealth Partners , Biogen Company Profile , Get Free Report , Director Eric , Wealth Partners , Financial Advisors , Street Partners Investment Advisory , Get Free , Biogen Daily , Nasdaq Biib ,